Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Pharmacol Res. 2019 Jul 25;147:104373. doi: 10.1016/j.phrs.2019.104373

Figure 4.

Figure 4.

Examples of MNPs where the supply problem was solved by development of scalable total syntheses (largazole, eribulin mesylate (HalavenĀ®), (+)-discodermolide and (+)-spongistatin 1), semisynthesis (puupehedione), heterologous expression (haliangicin), and mariculture (latrunculin B).